Lexby WheresMyMEPGet Pro free

Regulation (EU) 2022/839 laying down transitional rules for the packaging and labelling of veterinary medicinal products authorised or registered in accordance with Directive 2001/82/EC or Regulation (EC) No 726/2004 figure dans le corpus Pharmaceuticals & Life Sciences parce que son titre officiel correspond à medicinal products et veterinary medicinal. Source: EUR-Lex et dossier du Parlement européen; l'applicabilité à une entreprise dépend de ses activités. Methodology

Regulation (EU) 2022/839 laying down transitional rules for the packaging and labelling of veterinary medicinal products authorised or registered in accordance with Directive 2001/82/EC or Regulation (EC) No 726/2004: ce que cela signifie pour Pharmaceuticals & Life Sciences

Cette page explique en français pourquoi Regulation (EU) 2022/839 laying down transitional rules for the packaging and labelling of veterinary medicinal products authorised or registered in accordance with Directive 2001/82/EC or Regulation (EC) No 726/2004 est lié à Pharmaceuticals & Life Sciences. La correspondance est fondée sur les termes officiels medicinal products et veterinary medicinal; elle n'est pas un avis juridique.

Acte
32022R0839
Type
règlement
Étape
Procedure completed
Date
30 mai 2022
Procédure
2022/0053(COD)

Ce que fait l'acte

to avoid the risk of shortages of veterinary medicine products which would have led to a serious impact on animal health and welfare, both in farm and companion animals. PROPOSED ACT: Regulation of the European Parliament and of the Council. ROLE OF THE EUROPEAN PARLIAMENT: the European Parliament decides in accordance with the ordinary legislative procedure and on an equal footing with the Council. BACKGROUND: Regulation (EU) 2019/6 on veterinary medicinal products entered into force on 28 January 2022. Holders of marketing authorisations for veterinary medicinal products authorised under Directive 2001/82/EC...

Lire la fiche complète Regulation (EU) 2022/839 laying down transitional rules for the packaging and labelling of veterinary medicinal products authorised or registered in accordance with Directive 2001/82/EC or Regulation (EC) No 726/2004 →

Pourquoi cela compte pour Pharmaceuticals & Life Sciences

Pharmaceutical and life-sciences companies face EU rules on medicines authorisation, clinical trials and supply-chain integrity across the single market. These are the EU acts most likely to apply.

Lex publie la connexion source entre le texte officiel et le secteur; l'impact précis dépend de l'entreprise, de ses produits et de ses marchés.

Autres textes dans le corpus Pharmaceuticals & Life Sciences

Sources primaires

Données © Union européenne. Méthodologie.